Protica Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Protica Bio General Information

Description

Operator of a bio-convergence platform intended to provide efficient ways for immunotherapy treatments. The company's platform combines proteomics and computational biology to enhance the response rate to immunotherapy, mainly immune checkpoint inhibitors in solid tumors, enabling the healthcare industry to identify predictive markers of response and novel drug targets for combination therapies.

Contact Information

Website
www.protica.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • High-Tech Village Givat Ram Campus
  • P.O Box 39158
  • Jerusalem 91391
  • Israel
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • High-Tech Village Givat Ram Campus
  • P.O Box 39158
  • Jerusalem 91391
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Protica Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 15-May-2023 Completed Startup
2. Seed Round 01-Jul-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Protica Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Protica Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Protica Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
VLX Ventures Venture Capital Minority
BioGiv Excubator Accelerator/Incubator
To view Protica Bio’s complete investors history, request access »

Protica Bio FAQs

  • When was Protica Bio founded?

    Protica Bio was founded in 2021.

  • Where is Protica Bio headquartered?

    Protica Bio is headquartered in Jerusalem, Israel.

  • What is the size of Protica Bio?

    Protica Bio has 3 total employees.

  • What industry is Protica Bio in?

    Protica Bio’s primary industry is Other Healthcare Technology Systems.

  • Is Protica Bio a private or public company?

    Protica Bio is a Private company.

  • What is Protica Bio’s current revenue?

    The current revenue for Protica Bio is .

  • Who are Protica Bio’s investors?

    VLX Ventures and BioGiv Excubator have invested in Protica Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process